Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 18895475
[patent_doc_number] => 20240010960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => FORMATION OF ARRAYS OF PLANAR INTESTINAL CRYPTS POSSESSING A STEM/PROLIFERATIVE CELL COMPARTMENT AND DIFFERENTIATED CELL ZONE
[patent_app_type] => utility
[patent_app_number] => 18/371636
[patent_app_country] => US
[patent_app_date] => 2023-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18371636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/371636 | FORMATION OF ARRAYS OF PLANAR INTESTINAL CRYPTS POSSESSING A STEM/PROLIFERATIVE CELL COMPARTMENT AND DIFFERENTIATED CELL ZONE | Sep 21, 2023 | Pending |
Array
(
[id] => 18552387
[patent_doc_number] => 20230250396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHOD AND APPARATUS FOR IMPROVED MESENCHYMAL STEM CELL HARVESTING
[patent_app_type] => utility
[patent_app_number] => 18/137578
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18137578
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/137578 | METHOD AND APPARATUS FOR IMPROVED MESENCHYMAL STEM CELL HARVESTING | Apr 20, 2023 | Pending |
Array
(
[id] => 18567367
[patent_doc_number] => 20230257699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => NEURAL TISSUE UNIT AND USE OF SUCH A UNIT FOR IMPLANTATION INTO THE NERVOUS SYSTEM OF A MAMMAL
[patent_app_type] => utility
[patent_app_number] => 18/124921
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18124921
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/124921 | NEURAL TISSUE UNIT AND USE OF SUCH A UNIT FOR IMPLANTATION INTO THE NERVOUS SYSTEM OF A MAMMAL | Mar 21, 2023 | Pending |
Array
(
[id] => 18299745
[patent_doc_number] => 20230109431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHODS OF TREATING CANCER USING NK CELLS
[patent_app_type] => utility
[patent_app_number] => 18/077938
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18077938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/077938 | METHODS OF TREATING CANCER USING NK CELLS | Dec 7, 2022 | Pending |
Array
(
[id] => 18595998
[patent_doc_number] => 20230270789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMBINATORIAL CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/872827
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872827 | COMBINATORIAL CANCER IMMUNOTHERAPY | Jul 24, 2022 | Pending |
Array
(
[id] => 19258228
[patent_doc_number] => 12018274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Compositions and methods for regulating production of a fusion protein and ribonucleic acid
[patent_app_type] => utility
[patent_app_number] => 17/867881
[patent_app_country] => US
[patent_app_date] => 2022-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6613
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867881 | Compositions and methods for regulating production of a fusion protein and ribonucleic acid | Jul 18, 2022 | Issued |
Array
(
[id] => 18018166
[patent_doc_number] => 20220369665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Generation of Cell-Based Products for Human Consumption
[patent_app_type] => utility
[patent_app_number] => 17/661014
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17661014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/661014 | Generation of Cell-Based Products for Human Consumption | Apr 26, 2022 | Pending |
Array
(
[id] => 17789637
[patent_doc_number] => 20220248728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => SUBSTRATES FOR PREPARING A COMESTIBLE MEAT PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/660170
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660170 | Substrates for preparing a comestible meat product | Apr 20, 2022 | Issued |
Array
(
[id] => 17789636
[patent_doc_number] => 20220248727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS FOR PREPARING A COMESTIBLE MEAT PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/660165
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660165 | Methods for preparing a comestible meat product | Apr 20, 2022 | Issued |
Array
(
[id] => 19027495
[patent_doc_number] => 11926842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 and RH.39 in gene therapy vectors
[patent_app_type] => utility
[patent_app_number] => 17/590337
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 17968
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590337 | Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 and RH.39 in gene therapy vectors | Jan 31, 2022 | Issued |
Array
(
[id] => 18342033
[patent_doc_number] => 11639509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Methods and compositions for dual glycan binding AAV2.5 vector
[patent_app_type] => utility
[patent_app_number] => 17/581639
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25228
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581639 | Methods and compositions for dual glycan binding AAV2.5 vector | Jan 20, 2022 | Issued |
Array
(
[id] => 18077698
[patent_doc_number] => 20220403310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => PLANT FAT-BASED SCAFFOLDS FOR THE GROWTH OF CELL-BASED MEATS AND METHODS OF MAKING SUCH PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/572297
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572297 | Plant fat-based scaffolds for the growth of cell-based meats and methods of making such products | Jan 9, 2022 | Issued |
Array
(
[id] => 17655500
[patent_doc_number] => 20220175965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => AAV-ABCD1 CONSTRUCTS AND USE FOR TREATMENT OR PREVENTION OF ADRENOLEUKODYSTROPHY (ALD) AND/OR ADRENOMYELONEUROPATHY (AMN)
[patent_app_type] => utility
[patent_app_number] => 17/557409
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557409 | AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN) | Dec 20, 2021 | Issued |
Array
(
[id] => 17655500
[patent_doc_number] => 20220175965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => AAV-ABCD1 CONSTRUCTS AND USE FOR TREATMENT OR PREVENTION OF ADRENOLEUKODYSTROPHY (ALD) AND/OR ADRENOMYELONEUROPATHY (AMN)
[patent_app_type] => utility
[patent_app_number] => 17/557409
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557409 | AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN) | Dec 20, 2021 | Issued |
Array
(
[id] => 17701986
[patent_doc_number] => 20220201992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => COMPOSITIONS AND METHODS FOR PRODUCING GENETICALLY MODIFIED ANIMALS
[patent_app_type] => utility
[patent_app_number] => 17/538206
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/538206 | Compositions and methods for producing genetically modified animals | Nov 29, 2021 | Issued |
Array
(
[id] => 17761759
[patent_doc_number] => 20220235371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/464727
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464727 | SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS | Sep 1, 2021 | Pending |
Array
(
[id] => 17414059
[patent_doc_number] => 20220048963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => NUCLEAR REPROGRAMMING FACTOR AND INDUCED PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/445282
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445282 | NUCLEAR REPROGRAMMING FACTOR AND INDUCED PLURIPOTENT STEM CELLS | Aug 16, 2021 | Pending |
Array
(
[id] => 17355382
[patent_doc_number] => 20220016178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Generation Of Uniform Hepatocytes From Human Embryonic Stem Cells By Inhibiting TGF-BETA and Methods Of Maintaining Hepatic Cultures
[patent_app_type] => utility
[patent_app_number] => 17/443786
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443786 | Generation Of Uniform Hepatocytes From Human Embryonic Stem Cells By Inhibiting TGF-BETA and Methods Of Maintaining Hepatic Cultures | Jul 26, 2021 | Pending |
Array
(
[id] => 17398243
[patent_doc_number] => 20220040333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
[patent_app_type] => utility
[patent_app_number] => 17/373944
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373944 | Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease | Jul 12, 2021 | Pending |
Array
(
[id] => 17357077
[patent_doc_number] => 20220017873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Human Pluripotent Stem Cell-Based Models for Predictive Developmental Neural Toxicity
[patent_app_type] => utility
[patent_app_number] => 17/373523
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373523 | Human Pluripotent Stem Cell-Based Models for Predictive Developmental Neural Toxicity | Jul 11, 2021 | Pending |